OPTIMISE: Optimisation of treatment selection and follow-up in oligometastatic colorectal cancer – a ctDNA-guided phase II randomised approach. Study protocol

Authors

  • Louise Bach Callesen Department of Oncology, Aarhus University Hospital, Aarhus, Denmark
  • Torben Frøstrup Hansen Department of Oncology, Vejle Hospital, University Hospital of Southern Denmark, Vejle, Denmark
  • Rikke Fredslund Andersen Department of Biochemistry and Immunology, Vejle Hospital, University Hospital of Southern Denmark, Vejle, Denmark
  • Niels Pallisgaard Department of Pathology, Zealand University Hospital, Roskilde, Denmark
  • Stine Kramer Department of Nuclear Medicine & PET-Centre, Aarhus University Hospital, Aarhus, Denmark
  • Sven Schlander Department of Radiology, Aarhus University Hospital, Aarhus, Denmark
  • Søren Rafael Rafaelsen Department of Radiology, Vejle Hospital, University Hospital of Southern Denmark, Vejle, Denmark
  • Anders Kindberg Boysen Department of Oncology, Aarhus University Hospital, Aarhus, Denmark
  • Lars Henrik Jensen Department of Oncology, Vejle Hospital, University Hospital of Southern Denmark, Vejle, Denmark
  • Anders Jakobsen Department of Oncology, Vejle Hospital, University Hospital of Southern Denmark, Vejle, Denmark
  • Karen-Lise Garm Spindler Department of Oncology, Aarhus University Hospital, Aarhus, Denmark

DOI:

https://doi.org/10.1080/0284186X.2022.2116728

Abstract

No abstract available

Downloads

Download data is not yet available.

Downloads

Published

2022-09-02

How to Cite

Bach Callesen, L., Frøstrup Hansen, T., Fredslund Andersen, R., Pallisgaard, N., Kramer, S., Schlander, S., … Garm Spindler, K.-L. (2022). OPTIMISE: Optimisation of treatment selection and follow-up in oligometastatic colorectal cancer – a ctDNA-guided phase II randomised approach. Study protocol. Acta Oncologica, 61(9), 1152–1156. https://doi.org/10.1080/0284186X.2022.2116728

Issue

Vol. 61 No. 9 (2022): Acta Oncologica

Section

Articles